Replies to post #41988 on Ocata Therapeutics Inc fka OCAT

[johan31]

"Before making the formal application which ACT plans on doing soon they most likely have been through review process. If they didn't meet criteria of one of the listing standards then why would a Company even apply?"
Well I heard Rabin state it in the CC but I believe all mention of it was pulled from the definitive proxy.

So who knows what their plan is

thanks

johan

[farviewhill]

This is why, imo, as I've suggested before, Rabin and the Board have had positive enough talks and understanding with nasdaq to move forward as seemingly confidently as they are projectng.
Inherint in this posture and strategy by ACTC, must be some factors that will be so positive and arrangements with institutions so promising, that they feel comfortable that the RS price will be at a higher level today, than in a couple months and that positive developments will prevent damaging price erosion and increase the chances of price appreciation and the resulting momentum that goes with it.

I just cannot foresee the RS at lower price share levels, as it makes zero sense to me and makes the company's nasdaq staying power through it's share price incredibly tenuous.
Rabin, given his background, is just too savey in this area, to wing this on a hope and a prayer. I would be shocked if it turns out otherwise.